Dermal Filler - Medical Devices Pipeline Assessment, 2016

Publisher Name :
Date: 01-Dec-2016
No. of pages: 121

GlobalData's Medical Devices sector report, "Dermal Filler - Medical Devices Pipeline Assessment, 2016" provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Dermal Filler under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry


Reasons to buy

The report enables you to -


  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of Dermal Filler under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Dermal Filler - Medical Devices Pipeline Assessment, 2016

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9

2 Introduction 10
2.1 Dermal Filler Overview 10

3 Products under Development 11
3.1 Dermal Filler - Pipeline Products by Stage of Development 11
3.2 Dermal Filler - Pipeline Products by Territory 12
3.3 Dermal Filler - Pipeline Products by Regulatory Path 13
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date 14
3.5 Dermal Filler - Ongoing Clinical Trials 15

4 Dermal Filler - Pipeline Products under Development by Companies 16
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development 16
4.2 Dermal Filler - Pipeline Products by Stage of Development 18

5 Dermal Filler Companies and Product Overview 20
5.1 Aeon Astron Corporation Company Overview 20
5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Allergan Inc Company Overview 21
5.2.1 Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Anika Therapeutics Inc Company Overview 26
5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 BioPolymer GmbH & Co. KG Company Overview 28
5.4.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 Cytophil, Inc. Company Overview 31
5.5.1 Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.6 Cytosial Biomedic, S.a.s. Company Overview 32
5.6.1 Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 32
5.7 Dermele Skin Care, LLC Company Overview 34
5.7.1 Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 EternoGen, LLC Company Overview 35
5.8.1 EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 FibroGen Inc Company Overview 36
5.9.1 FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Galderma SA Company Overview 38
5.10.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 38
5.11 Innovia LLC Company Overview 49
5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.12 Juvenis Ltd. Company Overview 50
5.12.1 Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Khorionyx Company Overview 51
5.13.1 Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 L&C Bio Company Overview 52
5.14.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 52
5.15 Mentor Worldwide LLC Company Overview 53
5.15.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.16 Moma Therapeutics, Inc. Company Overview 55
5.16.1 Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.17 Mosaic Medical Technologies, Inc Company Overview 56
5.17.1 Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.18 Oligo Medic, Inc. Company Overview 57
5.18.1 Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.19 ORGEV Laboratories Company Overview 58
5.19.1 ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 58
5.20 PetVivo Holdings Inc Company Overview 69
5.20.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.21 Sekisui Medical Co Ltd Company Overview 71
5.21.1 Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
5.22 Shanghai Haohai Biological Technology Co Ltd Company Overview 72
5.22.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
5.23 Shin Poong PharmCo Ltd Company Overview 75
5.23.1 Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
5.24 Sinclair Pharma PLC Company Overview 76
5.24.1 Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 76
5.25 Sofregen Medical Inc Company Overview 87
5.25.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 TEI Biosciences Inc Company Overview 88
5.26.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88

6 Dermal Filler- Recent Developments 89
6.1 Nov 21, 2016: Merz Continues Its Growth in Aesthetics and Neurotoxins 89
6.2 Nov 15, 2016: BTG: Interim results 90
6.3 Nov 08, 2016: FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update 91
6.4 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 91
6.5 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 93
6.6 Oct 19, 2016: Facial Aesthetics First in Denver to Offer New Treatment to Help Patients Achieve "Goldilocks Lips" 94
6.7 Oct 18, 2016: JUVEDERM VOLBELLA XC Now Available To Doctors And Patients In The U.S. 94
6.8 Oct 10, 2016: Aesthetics Industry Veteran Pat Altavilla Joins Suneva Medical As Vice President Of Marketing 95
6.9 Oct 06, 2016: BTG: close period update 95
6.10 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 96
6.11 Sep 23, 2016: Biologica Technologies launches Allofill injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons 96
6.12 Sep 21, 2016: Sinclair Pharma: Second Interim Statement (Jan-Jun 2016) 97
6.13 Sep 01, 2016: Sinclair Pharma: Restructuring programme and Board change 98
6.14 Aug 08, 2016: FibroGen Reports Financial Results for the Second Quarter of 2016 99
6.15 Aug 04, 2016: Suneva Appoints Preston Romm To Chief Executive Officer And Fortifies Board Of Directors With Industry Leaders 99
6.16 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 100
6.17 Jul 27, 2016: BTG Announces Appointment of Non-executive Director 103
6.18 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 103
6.19 Jul 18, 2016: Trading update and notification of board changes £17.2m revenue in 1H calendar 2016 104
6.20 Jul 14, 2016: BTG: Annual General Meeting 104
6.21 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 105
6.22 Jun 19, 2016: Body Organ Biomedical to Raise USD5.4 Million in Rights Offering of Shares 105
6.23 Jun 16, 2016: Preston Romm Joins Suneva Medical As Chief Operating Officer 105
6.24 Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 106
6.25 Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 107
6.26 Jun 07, 2016: Merz Receives CE Mark for Radiesse (+) Lidocaine 107
6.27 Jun 01, 2016: JUVEDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids 108
6.28 May 17, 2016: BTG: Final Results 109
6.29 May 09, 2016: FibroGen Reports Financial Results for the First Quarter of 2016 113
6.30 Apr 05, 2016: BTG: Close Period Update 114
6.31 Feb 26, 2016: Galderma Delivers Innovation In Dermal Fillers With The Launch Of Restylane Lyft 115
6.32 Jan 21, 2016: RegenScientific launches its CE-marked Renú soft tissue volumizing filler at the International Masters Course on Aging Science (IMCAS) World Congress 2016 116
6.33 Jan 12, 2016: RegenScientific - Cytophil appoints Mr. Ron Renten as Vice President of Sales and Marketing for Aesthetics in Europe, the Middle East, and Africa 116

7 Appendix 118
7.1 Methodology 118
7.2 About GlobalData 121
7.3 Contact Us 121
7.4 Disclaimer 121

List of Tables

Table 1: Dermal Filler - Pipeline Products by Stage of Development 11
Table 2: Dermal Filler - Pipeline Products by Territory 12
Table 3: Dermal Filler - Pipeline Products by Regulatory Path 13
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14
Table 5: Dermal Filler - Ongoing Clinical Trials 15
Table 6: Dermal Filler Companies - Pipeline Products by Stage of Development 16
Table 7: Dermal Filler - Pipeline Products by Stage of Development 18
Table 8: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
Table 9: BioDermal Filler - Product Status 20
Table 10: BioDermal Filler - Product Description 20
Table 11: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 12: JUVEDERM Volbella - Product Status 21
Table 13: JUVEDERM Volbella - Product Description 21
Table 14: JUVEDERM VOLIFT - Product Status 22
Table 15: JUVEDERM VOLIFT - Product Description 22
Table 16: Juvederm VOLUMA XC - Product Status 22
Table 17: Juvederm VOLUMA XC - Product Description 23
Table 18: Allergan Inc - Ongoing Clinical Trials Overview 23
Table 19: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 24
Table 20: Juvederm VOLUMA XC - Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVEDERM VOLUMA XC for the Facial Temporal Regions 24
Table 21: Juvederm VOLUMA XC - Voluma Treatment of HIV Facial Lipoatrophy 24
Table 22: JUVEDERM VOLIFT - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 25
Table 23: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: Next Generation ELEVESS Dermal Filler - Product Status 26
Table 25: Next Generation ELEVESS Dermal Filler - Product Description 27
Table 26: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 28
Table 27: Matridex - Product Status 28
Table 28: Matridex - Product Description 29
Table 29: Matridur - Product Status 29
Table 30: Matridur - Product Description 30
Table 31: Matrigel - Product Status 30
Table 32: Matrigel - Product Description 30
Table 33: Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 34: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status 31
Table 35: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description 31
Table 36: Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 37: Chitoderm - Product Status 32
Table 38: Chitoderm - Product Description 32
Table 39: Cytosmile - Product Status 33
Table 40: Cytosmile - Product Description 33
Table 41: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Table 42: Gold Nanoparticle Dermal Filler - Product Status 34
Table 43: Gold Nanoparticle Dermal Filler - Product Description 34
Table 44: EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 45: Collagen Scaffold - Aesthetic Procedures - Product Status 35
Table 46: Collagen Scaffold - Aesthetic Procedures - Product Description 35
Table 47: FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 48: FG-5030 - Product Status 36
Table 49: FG-5030 - Product Description 37
Table 50: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 38
Table 51: Restylane Defyne - Product Status 38
Table 52: Restylane Defyne - Product Description 39
Table 53: Restylane Lidocaine - Product Status 39
Table 54: Restylane Lidocaine - Product Description 39
Table 55: Restylane Lyft - Hand Rejuvenation - Product Status 40
Table 56: Restylane Lyft - Hand Rejuvenation - Product Description 40
Table 57: Restylane Perlane - Product Status 40
Table 58: Restylane Perlane - Product Description 41
Table 59: Restylane Refyne - Product Status 41
Table 60: Restylane Refyne - Product Description 41
Table 61: Restylane Skinboosters Vital - Product Status 42
Table 62: Restylane Skinboosters Vital - Product Description 42
Table 63: Galderma SA - Ongoing Clinical Trials Overview 43
Table 64: Restylane Perlane - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population 44
Table 65: Restylane Refyne - A Multi-center, Non-comparative Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel Classic Lidocaine and Emervel Deep Lidocaine 45
Table 66: Restylane Lidocaine - A Randomized, Multi-center, Subject-blinded and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associated with Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride 46
Table 67: Restylane Lidocaine - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population 46
Table 68: Restylane Skinboosters Vital - A Randomized, Multi-center, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects 47
Table 69: Restylane Skinboosters Vital - A Randomized, Multi-center, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face 47
Table 70: Restylane Defyne - A Multi-center, Non-comparative Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel Classic Lidocaine and Emervel Deep Lidocaine 48
Table 71: Restylane Lyft - Hand Rejuvenation - A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft with Lidocaine Compared to No Treatment for Injection in the Dorsal Hand to Correct Volume Deficit 48
Table 72: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 73: Wrinkle Filler - Product Status 49
Table 74: Wrinkle Filler - Product Description 49
Table 75: Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 76: Tenergel - Product Status 50
Table 77: Tenergel - Product Description 50
Table 78: Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 51
Table 79: Autologous Globin Dermal Filler - Product Status 51
Table 80: Autologous Globin Dermal Filler - Product Description 51
Table 81: L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 52
Table 82: Micronized Acellular Dermal Filler - Product Status 52
Table 83: Micronized Acellular Dermal Filler - Product Description 52
Table 84: Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 53
Table 85: Prevelle Shape - Product Status 53
Table 86: Prevelle Shape - Product Description 53
Table 87: Puragen - Product Status 54
Table 88: Puragen - Product Description 54
Table 89: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 90: Restogel-131 - Product Status 55
Table 91: Restogel-131 - Product Description 55
Table 92: Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 93: Dermal Filler - Product Status 56
Table 94: Dermal Filler - Product Description 56
Table 95: Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 96: AntaRep - Product Status 57
Table 97: AntaRep - Product Description 57
Table 98: ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 58
Table 99: Macdermol 18 - Product Status 58
Table 100: Macdermol 18 - Product Description 59
Table 101: Macdermol 21 - Product Status 59
Table 102: Macdermol 21 - Product Description 60
Table 103: Macdermol 24 - Product Status 60
Table 104: Macdermol 24 - Product Description 61
Table 105: Macdermol 30 - Product Status 61
Table 106: Macdermol 30 - Product Description 62
Table 107: Macdermol Bio Lift - Product Status 62
Table 108: Macdermol Bio Lift - Product Description 63
Table 109: Macdermol Bio Revitalization - Product Status 63
Table 110: Macdermol Bio Revitalization - Product Description 64
Table 111: Macdermol Hydro - Product Status 64
Table 112: Macdermol Hydro - Product Description 65
Table 113: Macdermol Lips - Product Status 65
Table 114: Macdermol Lips - Product Description 66
Table 115: MacDermol R - Product Status 66
Table 116: MacDermol R - Product Description 66
Table 117: MacDermol S - Product Status 67
Table 118: MacDermol S - Product Description 67
Table 119: Macdermol Volume - Product Status 67
Table 120: Macdermol Volume - Product Description 68
Table 121: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Table 122: Dermal Filler - Product Status 69
Table 123: Dermal Filler - Product Description 69
Table 124: Dermal Filler - Lip - Product Status 70
Table 125: Dermal Filler - Lip - Product Description 70
Table 126: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
Table 127: NADGL - Product Status 71
Table 128: NADGL - Product Description 71
Table 129: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
Table 130: QST Gel - Product Status 72
Table 131: QST Gel - Product Description 72
Table 132: Second Generation Matrifill - Product Status 73
Table 133: Second Generation Matrifill - Product Description 73
Table 134: Third Generation Matrifill - Product Status 73
Table 135: Third Generation Matrifill - Product Description 74
Table 136: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
Table 137: Dermal Filler - Product Status 75
Table 138: Dermal Filler - Product Description 75
Table 139: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 76
Table 140: Atlean - Product Status 77
Table 141: Atlean - Product Description 77
Table 142: Ellanse Hands-M - Product Status 78
Table 143: Ellanse Hands-M - Product Description 78
Table 144: Ellanse Hands-S - Product Status 79
Table 145: Ellanse Hands-S - Product Description 79
Table 146: Ellansé Lidocaine - Product Status 80
Table 147: Ellansé Lidocaine - Product Description 80
Table 148: Ellansé-E - Product Status 81
Table 149: Ellansé-E - Product Description 81
Table 150: Ellansé-L - Product Status 82
Table 151: Ellansé-L - Product Description 82
Table 152: Ellansé-M - Product Status 83
Table 153: Ellansé-M - Product Description 83
Table 154: Ellansé-S - Product Status 84
Table 155: Ellansé-S - Product Description 84
Table 156: Perfectha G - Product Status 85
Table 157: Perfectha G - Product Description 85
Table 158: Perfectha Lidocaine - Product Status 85
Table 159: Perfectha Lidocaine - Product Description 86
Table 160: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 87
Table 161: Silk Protein - Tissue/Dermal Filler - Product Status 87
Table 162: Silk Protein - Tissue/Dermal Filler - Product Description 87
Table 163: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 164: Injectable Dermal Filler - Product Status 88
Table 165: Injectable Dermal Filler - Product Description 88
Table 166: Glossary 119

List of Figures

Figure 1: Dermal Filler - Pipeline Products by Stage of Development 11
Figure 2: Dermal Filler - Pipeline Products by Territory 12
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path 13
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14
Figure 5: Dermal Filler - Ongoing Clinical Trials 15

  • Global Bacterial Endotoxin Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 103
    The gram-negative organisms release endotoxins, the presence or absence of which is determined by the endotoxins tests. Scope of the Report: The global Bacterial Endotoxin Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regio......
  • Global LAL and Pyrogen Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 106
    Pyrogen is a type of microbial and non-microbial substance that causes fever. Hence, pyrogen testing is conducted to measure the presence of pyrogen that causes fever. Scope of the Report: The global LAL and Pyrogen Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also......
  • Global Automated Medication Dispensing Systems (AMDS) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 117
    An Automated Medication Dispensing Machine, or automated dispensing cabinet (ADC) is a computerized drug storage device or cabinet designed for hospitals. ADCs allow medications to be stored and dispensed near the point of care while controlling and tracking drug distribution. They also are called unit-based cabinets (UBCs), automated dispensing devices (ADDs), automated distribution cabinets or automated dispensing machines (ADMs). Scope of the Report: The global Automated......
  • Global Stomach Cancer Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 119
    Stomach Cancer Drugs are used to treat stomach malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: The global Stomach Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for ......
  • Global Single-use Endoscopes Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 122
    An endoscopy (looking inside) is used in medicine to look inside the body. The endoscopy procedure uses an endoscope to examine the interior of a hollow organ or cavity of the body. Unlike many other medical imaging techniques, endoscopes are inserted directly into the organ. Single-use Endoscopes are better in protecting against cross-contamination than reusable endoscopes. Scope of the Report: The worldwide market for Single-use Endoscopes is expected to grow at a CAGR of......
  • Global Cell Culture Bioreactors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 116
    Cell Culture Bioreactors are bioreactors used for cell culture and microbial fermentation applications that span process development, clinical trials, and large-scale commercial biomanufacturing. Scope of the Report: The worldwide market for Cell Culture Bioreactors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focu......
  • Global Autotransfusion Blood Bags Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 108
    Autotransfusion is the reinfusion of the patient's blood by collecting the blood from the thorax or peritoneal cavity after washing and antibiotic administration. Autotransfusion Blood Bags refer to Disposable Blood Bag which are used for Blood Autotransfusion. The volume varies from 300 ml to 1000 ml. Scope of the Report: The worldwide market for Autotransfusion Blood Bags is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2......
  • Global Autotransfusion Systems (ATS) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jul-2019        Price: US 3480 Onwards        Pages: 115
    Autotransfusion System (ATS) is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can ......
  • Global Electrical Stimulation Therapy Market Size, Status and Forecast 2019-2025
    Published: 17-Jul-2019        Price: US 3900 Onwards        Pages: 95
    Electrical stimulation, or e-stim, is a physical therapy treatment modality used to improve muscle function, decrease pain, or promote healing. In 2018, the global Electrical Stimulation Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Electrical Stimulation Therapy status, future forecast, growth opportunity, key market and key players. The study obje......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs